These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 23142960

  • 1. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, de Seze J.
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [Abstract] [Full Text] [Related]

  • 2. Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
    de Sèze J, Kremer L, Collongues N.
    Rev Neurol (Paris); 2016 Aug; 172(4-5):256-62. PubMed ID: 27157418
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.
    Sato DK, Lana-Peixoto MA, Fujihara K, de Seze J.
    Brain Pathol; 2013 Nov; 23(6):647-60. PubMed ID: 24118482
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [Abstract] [Full Text] [Related]

  • 16. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Sep 27; 13(1):280. PubMed ID: 27793206
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
    Yoshida M.
    Brain Nerve; 2010 Sep 27; 62(9):961-74. PubMed ID: 20844307
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y, Wu WP, Huang DH, Wu L.
    Zhonghua Yi Xue Za Zhi; 2012 Nov 20; 92(43):3032-5. PubMed ID: 23328372
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.